Chordate Medical Holding AB (publ)

Stockholm Stock Exchange CMH.ST

Chordate Medical Holding AB (publ) Free Cash Flow Yield on January 14, 2025: -179.14%

Chordate Medical Holding AB (publ) Free Cash Flow Yield is -179.14% on January 14, 2025, a -207.30% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.
  • Chordate Medical Holding AB (publ) 52-week high Free Cash Flow Yield is -45.26% on January 30, 2024, which is 74.73% above the current Free Cash Flow Yield.
  • Chordate Medical Holding AB (publ) 52-week low Free Cash Flow Yield is -328.31% on January 03, 2025, which is -83.27% below the current Free Cash Flow Yield.
  • Chordate Medical Holding AB (publ) average Free Cash Flow Yield for the last 52 weeks is -110.86%.
Key data
Date Free Cash Flow Yield Market Value Added (MVA) Price to Book Ratio (P/B) Price to Earnings Ratio (P/E)
Market news
Stockholm Stock Exchange: CMH.ST

Chordate Medical Holding AB (publ)

CEO Mr. Anders Weilandt
IPO Date Feb. 15, 2022
Location Sweden
Headquarters KistagAngen 20B
Employees 3
Sector Health Care
Industries
Pharmaceuticals
Description

Chordate Medical Holding AB (publ), a medical technology company, develops products and solutions for the treatment of chronic migraine and rhinitis in Sweden. It focuses on the ear-nose and throat area. The company was founded in 2005 and is based in Kista, Sweden.

Similar companies

CLS-B.ST

Clinical Laserthermia Systems AB (publ)

USD 0.28

-7.61%

StockViz Staff

January 15, 2025

Any question? Send us an email